Transit Time Modulation
Transit Time Modulation is a methodological strategy in oral targeted delivery that selectively alters the gastrointestinal transit kinetics of a drug formulation to achieve site-specific release by exploiting physiological or engineered temporal control mechanisms.
28
Publications
1.5K
Citations
122
Authors
40
Institutions
Publications per year
2017–2026
3
Parents
28
1–5 of 28
122
2
h-index
2
h-index
1
h-index
Cambridge University Hospitals NHS Foundation Trust, United Kingdom
1 publications · 55 citations
1
h-index
1
h-index
1–5 of 122
40

University of Nottingham
Nottingham, United Kingdom
3 h-index
10 publications
696 citations
Astellas Pharma (Japan)
Tokyo, Japan
2 h-index
7 publications
290 citations
Iowa State University
Ames, United States
2 h-index
3 publications
143 citations
Mayo Clinic
Rochester, United States
2 h-index
9 publications
1.3K citations
Universitätsmedizin Greifswald
Greifswald, Germany
1 h-index
5 publications
95 citations
Mundipharma (United Kingdom)
Cambridge, United Kingdom
1 h-index
4 publications
220 citations
Beijing University of Agriculture
Beijing, China
1 h-index
1 publications
41 citations
MRC Clinical Trials Unit at UCL
London, United Kingdom
1 h-index
1 publications
55 citations
1–8 of 40
2 publications · 126 citations
2
h-index
EJP · 2 publications · 80 citations
2
h-index
2 publications · 46 citations
2
h-index
1 publications · 164 citations
1
h-index
1 publications · 19 citations
1
h-index
1–5